Compensation in pancreatic beta-cell function in subjects with glucokinase mutations

Area of Science:

• Endocrinology
• Metabolic Research
• Molecular Biology

Background:

• Glucokinase (GCK) is crucial for glucose sensing in pancreatic beta-cells.
• Heterozygous GCK mutations impair insulin secretion, leading to glucose intolerance.
• Understanding the relationship between GCK activity and insulin release is vital for metabolic disease research.

Purpose of the Study:

• To investigate the relationship between in vivo insulin secretion and glucose flux through glucokinase.
• To compare beta-cell responsiveness in individuals with heterozygous GCK mutations versus healthy controls.
• To explore compensatory mechanisms in beta-cells under varying GCK mutation severity.

Main Methods:

• Combined previously published in vivo dose-response data with in vitro glucokinase enzymatic properties.
• Estimated glucose flux through glucokinase (GK flux) using a Michaelis-Menten kinetic model.
• Analyzed insulin secretion in subjects with mild and severe GCK mutations.

Main Results:

• In subjects with mild GCK mutations, reduced insulin secretion correlated directly with decreased GK flux.
• In subjects with severe GCK mutations, insulin secretion was less reduced than predicted, indicating compensation.
• A compensatory increase in beta-cell insulin secretory response was observed in severe mutation cases.

Conclusions:

• The severity of GCK mutation influences the degree of beta-cell compensation.
• Proposed model modifications include glucose-induced normal allele overexpression and glucokinase regulatory protein.
• These findings highlight beta-cell adaptability in response to impaired glucokinase function.